Eye drop recalls usa

AOA Urges Consultation Before Use of MSM Eye Drops Amid Eye Drop Recall Concerns

11 Sep 2024

The American Optometric Association (AOA) has issued a consumer alert urging individuals to consult their local optometrists before using or purchasing over-the-counter (OTC) eye drops, particularly MSM eye drops that claim to change eye color. This alert comes in the wake of ongoing concerns following an FDA-issued warning regarding potential contamination in certain MSM eye […]

Read More

Global Pharma Eye Drop: No Contamination Found After Rigorous Testing

27 Aug 2024

Recent testing has confirmed that India’s Global Pharma Healthcare Ltd. eye drops are free from contamination, following previous links to an outbreak of eye infections in the USA in 2023. This finding comes from reports by NDTV, which cite sources within India’s health ministry after a comprehensive investigation by the drug regulatory authority. Investigative Findings […]

Read More

Amazon to Stop Selling 7 Brands of Eyedrops Following FDA Warning

15 Aug 2024

Amazon has announced it will cease the sale of seven brands of eyedrops following a warning from the U.S. Food and Drug Administration (FDA). The FDA’s letter to Amazon’s CEO, Andrew Jassy, highlighted that these products were being sold as “unapproved new drugs” on the platform, violating federal regulations. The FDA’s concerns stem from the […]

Read More

Superbug from Human Eye Drops Outbreak Spreads to Dogs

12 Aug 2024

Two dogs treated at a New Jersey veterinary hospital last year tested positive for a rare, drug-resistant strain of bacteria. This strain, linked to a fatal outbreak in humans caused by now-recalled eye drops, was identified by a CDC investigator. The bacteria, known as carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa, was found in swabs from the lungs […]

Read More

Uncovering the Truth: The Complete Timeline of the FDA/CDC Eye Drop Recall

01 Aug 2024

The outbreak of eye infections linked to contaminated eye drops in the United States has caused significant concern and action from health authorities. This detailed timeline follows the unfolding events that led to the involvement of the FDA and CDC and the subsequent recalls of various eye drop products. From the initial identification of the […]

Read More

The Voluntary Recall Process of the FDA: A Recent Case of Eye Drops Recall

19 Jul 2024

The safety of consumers is paramount in the pharmaceutical industry, and the U.S. Food and Drug Administration (FDA) plays a crucial role in ensuring that medical products meet high standards. One of the mechanisms the FDA uses to protect public health is the voluntary recall process. Recently, this process was prominently featured in the recall […]

Read More

Ensuring the Safe Use of Eye Products: Comprehensive Guidelines

12 Jul 2024

Dozens of eye drops and ointments have been pulled from store shelves after a wave of recalls in 2023 and 2024, raising concerns about whether products used to relieve dry or irritated eyes are safe. Most recently, Brassica Pharma voluntarily pulled four eye ointments from stores including Walmart and CVS. This happened after the Food […]

Read More
eye drop recall

FDA Warning: Risks Associated with South Moon, Rebright, and FivFivGo Eye Drops

19 Jun 2024

On February 3, 2024, the Food and Drug Administration (FDA) issued a critical warning to consumers, urging them not to purchase or use below mentioned eye drops due to the significant risk of eye infection. This cautionary advisory was prompted by the FDA’s commitment to ensuring the safety and well-being of the general public. The […]

Read More
Eye Drop Product Recall

Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk

17 Jun 2024

The FDA has ordered certain eye ointment products sold at major retailers including Walmart and CVS to be recalled due to infection risks. After thorough research and investigations, these products have been found to harbor harmful pseudomonas aeruginosa bacteria, posing a serious risk of eye infections. The recall affects a range of ointments used to […]

Read More
Eye Drop Recall

The Harvard Drug Group Issued Recall of Rugby® Laboratories Brand Eye Drops

11 Jun 2024

The Harvard Drug Group, LLC complied with a request by the FDA and undertook a voluntary nationwide recall of certain Rugby Laboratories Brand Eye Drops that were supplied by Velocity Pharma, LLC, because of a potential risk of eye infections. This recall was initiated by The Harvard Drug Group, LLC d/b/a Major® Pharmaceutical and Rugby® […]

Read More
List of contaminated eye drop products

Contaminated Eye Drop Products

22 May 2024

An outbreak of infections caused by drug-resistant bacteria that have led to significant health concerns across the United States came from multiple eye drop products: The FDA has identified bacterial and fungal contamination in these products: Notably, both products contain methylsulfonylmethane (MSM) as their active ingredient, a substance not commonly found in legally marketed eye […]

Read More
Eye drop recalls usa

Eye Drop Recalls: A Lesson in Pharmaceutical Vigilance

08 May 2024

The world of pharmaceuticals is often marred by controversies and recalls, leading to false accusations and widespread concern among consumers. Highlighting the importance of vigilance and rigorous standards prior to coming to conclusions and assigning blame. Media outlets bear a significant responsibility in ensuring their reporting is accurate, fair, and balanced. When they cast blame […]

Read More
Eye drop recalls usa

Additional eye drops recalled by FDA

24 Apr 2024

On March, 2023, additional eyedrop products were flagged for potential safety concerns, prompting widespread alarm among consumers and healthcare professionals alike. The public outcry was swift and intense as news of the additional recalls spread. Many questioned the manufacturing processes of these companies, with evidence mounting that these companies and manufacturers could be the root […]

Read More
Eye drop recall

Investigation Reveals No Contaminants in Global Pharma Healthcare’s Eye Drops

10 Apr 2024

The Indian drug regulator, in its thorough investigation into the widely publicized multistate outbreak of an extensively drug-resistant bacterium strain linked to various infections, has found no contaminants in the eye drops manufactured by Chennai-based Global Pharma Healthcare. Control samples collected from the manufacturing plant near Chennai by the Indian drug regulator were scrutinized, and […]

Read More